Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 1, 2022
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 27
| |||||||
Passage Bio, Inc.
| 10K |
$3.15 | $31,500.00 | +167.14% | 15.98K |
Mar 21
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 10
| |||||||
Passage Bio, Inc.
| 2K |
$13.12 | $26,230.00 | +50.21% | 5.98K |
May 21
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 16
| |||||||
Passage Bio, Inc.
| 1.1K |
$18.00 | $19,800.00 |
∞
| 1.1K |
Mar 3
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Allos Therapeutics Inc
| -346.93K |
$1.82 | -$631,418.06 | -100.00% |
0
| +1 |
Sep 4
| ||||||
Allos Therapeutics Inc
| 170.75K |
$1.51 | -$13,559.49 | +96.92% | 346.93K | +1 |
Feb 28 - Mar 1
|
Scheduled
| |||||
Allos Therapeutics Inc
| -3.08K |
$1.58 | -$4,846.09 | -1.72% | 176.18K | +1 |
Feb 23 - Feb 24
|
Scheduled
| |||||
Allos Therapeutics Inc
| -12.77K |
$1.44 | -$18,437.70 | -6.65% | 179.26K | +1 |
Nov 15 - Nov 16
|
Scheduled
| |||||
Allos Therapeutics Inc
| 67.3K |
—
|
—
| +53.96% | 192.02K | +1 |
Feb 28
| ||||||
Allos Therapeutics Inc
| -2.76K |
$3.23 | -$8,895.10 | -2.16% | 124.73K | +1 |
Feb 23 - Feb 24
|
Scheduled
| |||||
Allos Therapeutics Inc
| 100.67K |
—
|
—
| +375.47% | 127.48K | +1 |
Oct 20
| ||||||
Allos Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Allos Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||